The new report by Expert Market Research titled, ‘Global Risk-Based Monitoring Software Market Size, Growth, Trend, Analysis, Report and Forecast 2022-2027’, gives an in-depth analysis of the global risk-based monitoring software market, assessing the market based on its segments like types, components, delivery modes, end uses, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators and analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview 2017-2027
- Historical Market Size (2020): Around USD 278 Million
- Forecast CAGR (2022-2027): 6%
The risk-based monitoring software industry is being driven by the growing number of clinical trials. This can be attributed to rising incidences of chronic illnesses, that is driving the demand for efficient drug development to aid in the treatment process. In addition, clinical trials aid in evaluating medical, surgical or behavioural interventions, which helps medical practitioners determine the effectiveness of medical devices, drugs or diet, which is expected to augment the market growth in the coming years. As web-based risk-based monitoring software offers cost-effectiveness, enhanced scalability and integration, as well as customisability, its demand is significantly surging, which is predicted to propel the industry growth in the forecast period.
Risk-Based Monitoring Software Industry Definition and Major Segments
Risk-based monitoring software is a technology that helps to identify, monitor, and assess any potential risks in the process of an ongoing study or research, which may pose a risk to the quality or safety of the subjects involved. This allows for pharmaceutical, medical devices, and biopharmaceutical companies to take swift decisions in order to mitigate the negatively impacting risks.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/risk-based-monitoring-software-market/requestsample
The market, on the basis of type, can be segmented into:
- Enterprise RBM Software
- Site RBM Software
Based on component, the industry can be segregated into:
On the basis of delivery mode, the market can be classified into:
- Web-Based (On-Demand)
- Licensed Enterprise (On-Premise)
- Cloud-Based (SAAS)
Based on end use, the industry can be categorised into:
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organisations (CROs)
- Medical Device Companies
The regional markets for risk-based monitoring software include:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Risk-Based Monitoring Software Market Trends
The global risk-based monitoring software industry is being driven by the increased demand for RBM software in the pharmaceutical and biopharmaceutical industry. In addition, the rising government investments to support essential clinical trials are expected to boost the usage of risk-based monitoring technology, which is expected to positively impact market growth. Rapid technological advancements and innovations such as the integration of cloud technology and artificial intelligence (AI) in the software are further estimated to aid the market growth. The factors are anticipated to aid the market growth in the coming years.
Key Market Players
The major players in the market are Oracle Corporation, Medidata Solutions, Inc., Veeva Systems, IBM Corporation, and DATATRAK International, Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: James Rowan, Business Consultant
Email: [email protected]
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA